vimarsana.com
Home
Live Updates
China Precision Medicine Business Opportunities Databook 2023: Focus on Mepolizumab, Osimertinib, Aripiprazole Lauroxil, & Alectinib - ResearchAndMarkets.com : vimarsana.com
China Precision Medicine Business Opportunities Databook 2023: Focus on Mepolizumab, Osimertinib, Aripiprazole Lauroxil, & Alectinib - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 13, 2023--
Related Keywords
China
,
Aripiprazole Lauroxil
,
Laura Wood
,
Diagnostics Companies
,
Technology Platforms
,
E St Office Hours Call
,
Biotechnology Companies
,
Office Hours Call
,
Ion Semiconductor
,
Route Of Administration
,
Healthcare It Specialists Big Data Companies
,
Topics Covered
,
Precision Medicine Market Size
,
Precision Medicine Market Share
,
Medicine Market Size
,
Cloud Based Platform
,
On Premise Platform
,
Big Data Analytics
,
Drug Discovery
,
Companion Diagnostics
,
Gene Sequencing
,
Chain Termination Sequencing
,
Nanopore Sequencing
,
Ion Semiconductor Sequencing
,
Single Molecule Real Time Sequencing
,
Infectious Diseases
,
End User
,
Big Data Companies
,
Clinical Laboratories
,
Senior Press
,
Free Call
,
Hours Call
,
Business Wire
,
Business
,
Ews Ap
,
vimarsana.com © 2020. All Rights Reserved.